{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T18:37:21Z","timestamp":1772217441347,"version":"3.50.1"},"reference-count":125,"publisher":"Public Library of Science (PLoS)","issue":"8","license":[{"start":{"date-parts":[[2023,8,9]],"date-time":"2023-08-09T00:00:00Z","timestamp":1691539200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100019418","name":"NIHR Maudsley Biomedical Research Centre","doi-asserted-by":"publisher","award":["IS-BRC-1215-20018"],"award-info":[{"award-number":["IS-BRC-1215-20018"]}],"id":[{"id":"10.13039\/100019418","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:sec id=\"sec001\">\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>Various definitions have been proposed for Refractory Disease in people with Rheumatoid Arthritis; however, none were generated for Polyarticular Juvenile Idiopathic Arthritis or involving adult and paediatric multidisciplinary healthcare professionals and patients. The study aim is to redefine Refractory Disease, using Delphi methodology.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec002\">\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Three rounds of surveys (one nominal group and two online (2019\u20132020)) to achieve consensus using a predetermined cut-off were conducted voting on: a) name, b) treatment and inflammation, c) symptoms and impact domains, and d) rating of individual components within domains. Theoretical application of the definition was conducted through a scoping exercise.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec003\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Votes were collected across three rounds from Patients, Researchers and nine multi-disciplinary healthcare professional groups (n = 106). Refractory Inflammatory Arthritis was the most popular name. Regarding treatment and inflammation, these were voted to be kept broad rather than specifying numbers\/cut-offs. From 10 domains identified to capture symptoms and disease impact, six domains reached consensus for inclusion: 1) Disease Activity, 2) Joint Involvement, 3) Pain, 4) Fatigue, 5) Functioning and Quality of Life, and 6) Disease-Modifying Anti-Rheumatic Drug Experiences. Within these domains, 18 components, from an initial pool (n = 73), were identified as related and important to capture multi-faceted presentation of Refractory Inflammatory Arthritis, specifically in Rheumatoid Arthritis and Polyarticular Juvenile Idiopathic Arthritis. Feasibility of the revised definition was established (2022\u20132023) with good utility as was applied to 82% of datasets (n = 61) incorporating 20 outcome measures, with two further measures added to increase its utility and coverage of Pain and Fatigue.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec004\">\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Refractory Inflammatory Arthritis has been found to be broader than not achieving low disease activity, with wider biopsychosocial components and factors incorporating Persistent Inflammation or Symptoms identified as important. This definition needs further refinement to assess utility as a classification tool to identify patients with unmet needs.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1371\/journal.pone.0289760","type":"journal-article","created":{"date-parts":[[2023,8,9]],"date-time":"2023-08-09T13:30:53Z","timestamp":1691587853000},"page":"e0289760","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":6,"title":["Refractory inflammatory arthritis definition and model generated through patient and multi-disciplinary professional modified Delphi process"],"prefix":"10.1371","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9402-9669","authenticated-orcid":true,"given":"Hema","family":"Chaplin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ailsa","family":"Bosworth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carol","family":"Simpson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kate","family":"Wilkins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jessica","family":"Meehan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena","family":"Nikiphorou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rona","family":"Moss-Morris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heidi","family":"Lempp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sam","family":"Norton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2023,8,9]]},"reference":[{"issue":"8","key":"pone.0289760.ref001","doi-asserted-by":"crossref","first-page":"3540","DOI":"10.1093\/rheumatology\/keab237","article-title":"Summarizing current refractory disease definitions in rheumatoid arthritis and polyarticular juvenile idiopathic arthritis: systematic review.","volume":"60","author":"H Chaplin","year":"2021","journal-title":"Rheumatology"},{"key":"pone.0289760.ref002","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1136\/annrheumdis-2020-217344","article-title":"EULAR definition of difficult-to-treat rheumatoid arthritis","volume":"80","author":"G Nagy","year":"2020","journal-title":"Annals of the Rheumatic Diseases"},{"issue":"11","key":"pone.0289760.ref003","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.autrev.2011.04.023","article-title":"Rheumatoid arthritis: what is refractory disease and how to manage it?","volume":"10","author":"J Polido-Pereira","year":"2011","journal-title":"Autoimmun Rev"},{"issue":"10","key":"pone.0289760.ref004","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1136\/annrheumdis-2018-213378","article-title":"Biologic refractory disease in rheumatoid arthritis: results from the British Society for Rheumatology Biologics Register for Rheumatoid Arthritis","volume":"77","author":"L Kearsley-Fleet","year":"2018","journal-title":"Ann Rheum Dis"},{"issue":"7","key":"pone.0289760.ref005","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1136\/annrheumdis-2017-212862","article-title":"Defining refractory rheumatoid arthritis","volume":"77","author":"MH Buch","year":"2018","journal-title":"Annals of the Rheumatic Diseases"},{"issue":"6","key":"pone.0289760.ref006","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1002\/art.40844","article-title":"Further Considerations of the Need for Integrated Mental Health Treatment in Rheumatoid Arthritis Patients: Comment on the Review by Matcham et al.","volume":"71","author":"H Zembrzuska","year":"2019","journal-title":"Arthritis & Rheumatology."},{"issue":"9","key":"pone.0289760.ref007","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.1093\/rheumatology\/kez635","article-title":"Secular changes in the progression of clinical markers and patient-reported outcomes in early rheumatoid arthritis.","volume":"59","author":"L Carpenter","year":"2020","journal-title":"Rheumatology"},{"issue":"1","key":"pone.0289760.ref008","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1002\/art.41461","article-title":"Treat-to-Target From the Patient Perspective Is Bowling for a Perfect Strike.","volume":"73","author":"CG Schoemaker","year":"2021","journal-title":"Arthritis & Rheumatology."},{"issue":"11","key":"pone.0289760.ref009","doi-asserted-by":"crossref","first-page":"2076","DOI":"10.1093\/rheumatology\/kev239","article-title":"The impact of multimorbidity status on treatment response in rheumatoid arthritis patients initiating disease-modifying anti-rheumatic drugs.","volume":"54","author":"H Radner","year":"2015","journal-title":"Rheumatology"},{"key":"pone.0289760.ref010","author":"A. Young","year":"2015","journal-title":"Minutes from ARUK clinical study group refractory disease workshop: Prevalence of refractory disease in the UK"},{"key":"pone.0289760.ref011","author":"BANNAR","year":"2017","journal-title":"BANNAR statement of understanding of current clinical practice for biologic and biosimilar use in JIA in the UK"},{"issue":"2","key":"pone.0289760.ref012","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.paed.2017.10.010","article-title":"Outcomes for juvenile idiopathic arthritis","volume":"28","author":"K. Armon","year":"2018","journal-title":"Paediatrics and Child Health"},{"issue":"Suppl 1","key":"pone.0289760.ref013","doi-asserted-by":"crossref","first-page":"P193","DOI":"10.1186\/1546-0096-12-S1-P193","article-title":"Juvenile idiopathic arthritis: the transition to adulthood.","volume":"12","author":"S Fernandes","year":"2014","journal-title":"Pediatric rheumatology online journal"},{"issue":"9596","key":"pone.0289760.ref014","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1016\/S0140-6736(07)61602-X","article-title":"The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies.","volume":"370","author":"E von Elm","year":"2007","journal-title":"Lancet"},{"issue":"3","key":"pone.0289760.ref015","first-page":"655","article-title":"How to use the nominal group and Delphi techniques","volume":"38","author":"SS McMillan","year":"2016","journal-title":"International journal of clinical pharmacy"},{"issue":"Suppl 2","key":"pone.0289760.ref016","first-page":"1646","article-title":"AB0372\u2005Exploring Refractory Disease & Persistent Symptoms in RA\/PolyJIA despite bDMARDS: Patient & Professional Experiences","volume":"78","author":"H Chaplin","year":"2019","journal-title":"Annals of the Rheumatic Diseases"},{"issue":"2","key":"pone.0289760.ref017","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1002\/pon.3578","article-title":"Experiences of paradox: a qualitative analysis of living with cancer using a framework approach","volume":"24","author":"I Leal","year":"2015","journal-title":"Psycho-Oncology"},{"key":"pone.0289760.ref018","volume-title":"Analyzing Qualitative Data","author":"J Ritchie","year":"1994"},{"issue":"7","key":"pone.0289760.ref019","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1097\/01.chi.0000125090.35109.57","article-title":"Formulation: Putting the Diagnosis Into a Therapeutic Context and Treatment Plan.","volume":"43","author":"MS Jellinek","year":"2004","journal-title":"Journal of the American Academy of Child & Adolescent Psychiatry."},{"issue":"1","key":"pone.0289760.ref020","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.chc.2006.07.010","article-title":"The case formulation in child and adolescent psychiatry.","volume":"16","author":"NC Winters","year":"2007","journal-title":"Child and adolescent psychiatric clinics of North America."},{"issue":"5","key":"pone.0289760.ref021","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1097\/PSY.0000000000001076","article-title":"An Evidence-Based Theory of Psychological Adjustment to Long-Term Physical Health Conditions: Applications in Clinical Practice.","volume":"84","author":"S Carroll","year":"2022","journal-title":"Psychosomatic Medicine."},{"key":"pone.0289760.ref022","first-page":"7","volume-title":"Medical psychology.","author":"H Leventhal","year":"1980"},{"issue":"4","key":"pone.0289760.ref023","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1111\/bjhp.12072","article-title":"Adjusting to chronic illness: time for a unified theory","volume":"18","author":"R. Moss-Morris","year":"2013","journal-title":"Br J Health Psychol"},{"issue":"3","key":"pone.0289760.ref024","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.rcreue.2019.04.007","article-title":"The Delphi method in rheumatology research: are we doing it right?","volume":"27","author":"DG Fern\u00e1ndez-\u00c1vila","year":"2020","journal-title":"Revista Colombiana de Reumatolog\u00eda (English Edition)."},{"issue":"S10","key":"pone.0289760.ref025","first-page":"1","article-title":"Patient Outcomes in Rheumatology, 2020 A Review of Measures [Special Issue].","volume":"72","author":"M Hannan","year":"2020","journal-title":"Arthritis Care & Research."},{"issue":"8","key":"pone.0289760.ref026","article-title":"Development and initial cohort validation of the Arthritis Research UK Musculoskeletal Health Questionnaire (MSK-HQ) for use across musculoskeletal care pathways.","volume":"6","author":"JC Hill","year":"2016","journal-title":"BMJ Open."},{"issue":"2","key":"pone.0289760.ref027","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1002\/art.1780230202","article-title":"Measurement of patient outcome in arthritis","volume":"23","author":"JF Fries","year":"1980","journal-title":"Arthritis and rheumatism"},{"issue":"12","key":"pone.0289760.ref028","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1002\/art.1780371209","article-title":"Measurement of health status in children with juvenile rheumatoid arthritis","volume":"37","author":"G Singh","year":"1994","journal-title":"Arthritis and rheumatism"},{"issue":"1","key":"pone.0289760.ref029","doi-asserted-by":"crossref","first-page":"56","DOI":"10.7748\/nr2008.10.16.1.56.c6753","article-title":"Using the consensus development conference method in healthcare research","volume":"16","author":"E Halcomb","year":"2008","journal-title":"Nurse researcher"},{"issue":"10","key":"pone.0289760.ref030","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1007\/s12325-015-0249-6","article-title":"Development of a Consensus Statement for the Definition, Diagnosis, and Treatment of Acute Exacerbations of Idiopathic Pulmonary Fibrosis Using the Delphi Technique.","volume":"32","author":"TM Maher","year":"2015","journal-title":"Adv Ther."},{"issue":"3","key":"pone.0289760.ref031","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1007\/s10926-016-9674-x","article-title":"Limitations to Work-Related Functioning of People with Persistent \"Medically Unexplained\" Physical Symptoms: A Modified Delphi Study Among Physicians.","volume":"27","author":"KHN Weerdesteijn","year":"2017","journal-title":"J Occup Rehabil."},{"issue":"2","key":"pone.0289760.ref032","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1136\/annrheumdis-2017-212141","article-title":"Development of a consensus core dataset in juvenile dermatomyositis for clinical use to inform research","volume":"77","author":"LJ McCann","year":"2018","journal-title":"Annals of the Rheumatic Diseases"},{"issue":"7","key":"pone.0289760.ref033","doi-asserted-by":"crossref","first-page":"2374","DOI":"10.1007\/s11999-013-2866-1","article-title":"Success After Treatment of Periprosthetic Joint Infection: A Delphi-based International Multidisciplinary Consensus","volume":"471","author":"C Diaz-Ledezma","year":"2013","journal-title":"Clinical Orthopaedics and Related Research\u00ae"},{"issue":"4","key":"pone.0289760.ref034","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1002\/nur.20199","article-title":"Is the CVI an acceptable indicator of content validity? Appraisal and recommendations","volume":"30","author":"DF Polit","year":"2007","journal-title":"Res Nurs Health."},{"issue":"9","key":"pone.0289760.ref035","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1002\/acr.22602","article-title":"Consistency and Utility of Data Items Across European Rheumatoid Arthritis Clinical Cohorts and Registers.","volume":"67","author":"H Radner","year":"2015","journal-title":"Arthritis Care & Research."},{"issue":"1","key":"pone.0289760.ref036","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s12969-017-0161-5","article-title":"A survey of national and multi-national registries and cohort studies in juvenile idiopathic arthritis: challenges and opportunities.","volume":"15","author":"T Beukelman","year":"2017","journal-title":"Pediatric Rheumatology"},{"issue":"3","key":"pone.0289760.ref037","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.semarthrit.2018.03.006","article-title":"The use of routinely collected patient-reported outcome measures in rheumatoid arthritis","volume":"48","author":"M Hiligsmann","year":"2018","journal-title":"Seminars in Arthritis and Rheumatism"},{"issue":"1","key":"pone.0289760.ref038","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.berh.2008.12.005","article-title":"What have we learnt from early rheumatoid arthritis cohorts?","volume":"23","author":"A. Young","year":"2009","journal-title":"Best Practice & Research Clinical Rheumatology."},{"issue":"10","key":"pone.0289760.ref039","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1136\/annrheumdis-2022-222586","article-title":"Effectiveness of TNF-inhibitors, abatacept, IL6-inhibitors and JAK-inhibitors in 31 846 patients with rheumatoid arthritis in 19 registers from the \u2018JAK-pot\u2019 collaboration.","volume":"81","author":"K Lauper","year":"2022","journal-title":"Annals of the Rheumatic Diseases"},{"key":"pone.0289760.ref040","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1093\/med\/9780199642489.001.0001","volume-title":"Oxford Textbook of Rheumatology","author":"RA Watts","year":"2013"},{"issue":"3","key":"pone.0289760.ref041","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/0168-8510(90)90421-9","article-title":"EuroQol\u2014a new facility for the measurement of health-related quality of life.","volume":"16","author":"EuroQol Group","year":"1990","journal-title":"Health Policy."},{"issue":"2","key":"pone.0289760.ref042","doi-asserted-by":"crossref","first-page":"191","DOI":"10.3899\/jrheum.100700","article-title":"The Impact Triad (Severity, Importance, Self-management) as a Method of Enhancing Measurement of Personal Life Impact of Rheumatic Diseases.","volume":"38","author":"TC Sanderson","year":"2011","journal-title":"The Journal of Rheumatology"},{"issue":"6","key":"pone.0289760.ref043","first-page":"1089","article-title":"Biologic therapy in rheumatoid arthritis: results from the Romanian registry of rheumatic diseases one year after initiation.","volume":"62","author":"C Codreanu","year":"2014","journal-title":"Farmacia"},{"issue":"8","key":"pone.0289760.ref044","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1007\/s00296-005-0054-7","article-title":"Classic disease modifying anti-rheumatic drugs (DMARDs) in combination with infliximab. The Finnish experience","volume":"26","author":"DC Nordstr\u00f6m","year":"2006","journal-title":"Rheumatology International."},{"issue":"1","key":"pone.0289760.ref045","first-page":"45","article-title":"Reuma.pt\u2014the rheumatic diseases portuguese register.","volume":"36","author":"H Canh\u00e3o","year":"2011","journal-title":"Acta Reumatol Port"},{"issue":"3","key":"pone.0289760.ref046","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1002\/acr.22126","article-title":"Quality of life and health care use in patients with arthralgias without synovitis compared with patients diagnosed with early rheumatoid arthritis: data from an early arthritis cohort.","volume":"66","author":"TM Kuijper","year":"2014","journal-title":"Arthritis Care & Research."},{"issue":"9","key":"pone.0289760.ref047","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1136\/ard.2010.142299","article-title":"Diagnostic performance of the ACR\/EULAR 2010 criteria for rheumatoid arthritis and two diagnostic algorithms in an early arthritis clinic (REACH).","volume":"70","author":"C Alves","year":"2011","journal-title":"Annals of the rheumatic diseases"},{"issue":"8","key":"pone.0289760.ref048","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1002\/art.24539","article-title":"Predictors of early inactive disease in a juvenile idiopathic arthritis cohort: results of a Canadian multicenter, prospective inception cohort study","volume":"61","author":"K Oen","year":"2009","journal-title":"Arthritis Rheum"},{"issue":"1","key":"pone.0289760.ref049","doi-asserted-by":"crossref","first-page":"21","DOI":"10.3899\/jrheum.100347","article-title":"Rheumatoid arthritis disease-modifying antirheumatic drug intervention and utilization study: safety and etanercept utilization analyses from the RADIUS 1 and RADIUS 2 registries","volume":"38","author":"A Gibofsky","year":"2011","journal-title":"The Journal of rheumatology"},{"issue":"10","key":"pone.0289760.ref050","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1093\/rheumatology\/kev194","article-title":"Health-related quality of life in patients with long-standing rheumatoid arthritis in the era of biologics: data from the German biologics register RABBIT.","volume":"54","author":"K Gerhold","year":"2015","journal-title":"Rheumatology"},{"issue":"11","key":"pone.0289760.ref051","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1136\/ard.2006.069252","article-title":"QUEST-RA: quantitative clinical assessment of patients with rheumatoid arthritis seen in standard rheumatology care in 15 countries","volume":"66","author":"T Sokka","year":"2007","journal-title":"Annals of the Rheumatic Diseases"},{"key":"pone.0289760.ref052","first-page":"35","article-title":"The population based studies in rheumatoid arthritis. A method of longterm followup studies","volume":"69","author":"TK Kvien","year":"2004","journal-title":"The Journal of Rheumatology"},{"issue":"3","key":"pone.0289760.ref053","first-page":"622","article-title":"Health care provision in pediatric rheumatology in Germany\u2014national rheumatologic database","volume":"29","author":"K Minden","year":"2002","journal-title":"The Journal of Rheumatology"},{"issue":"5 Suppl 85","key":"pone.0289760.ref054","first-page":"158","article-title":"NOR-DMARD data management: implementation of data capture from electronic health records","volume":"32","author":"I Olsen","year":"2014","journal-title":"Clin Exp Rheumatol"},{"issue":"9","key":"pone.0289760.ref055","doi-asserted-by":"crossref","first-page":"2809","DOI":"10.1002\/art.30426","article-title":"Ongoing disease activity and changing categories in a long-term nordic cohort study of juvenile idiopathic arthritis","volume":"63","author":"E Nordal","year":"2011","journal-title":"Arthritis Rheum"},{"issue":"5; SUPP 31","key":"pone.0289760.ref056","first-page":"S94","article-title":"The norfolk arthritis register (NOAR).","volume":"21","author":"D Symmons","year":"2003","journal-title":"Clinical and experimental rheumatology"},{"issue":"11","key":"pone.0289760.ref057","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.3899\/jrheum.141498","article-title":"The Longitudinal Course of Fatigue in Rheumatoid Arthritis: Results from the Norfolk Arthritis Register","volume":"42","author":"KL Druce","year":"2015","journal-title":"The Journal of Rheumatology"},{"key":"pone.0289760.ref058","first-page":"14","article-title":"The Nijmegen inception cohort of early rheumatoid arthritis","volume":"69","author":"PM Welsing","year":"2004","journal-title":"J Rheumatol Suppl"},{"key":"pone.0289760.ref059","author":"British Society of Rheumatology.","year":"2019","journal-title":"National Early Inflammatory Arthritis Audit (NEIAA) 1st Annual Report"},{"issue":"1","key":"pone.0289760.ref060","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1093\/rheumatology\/keq155","article-title":"The National Data Bank for rheumatic diseases: a multi-registry rheumatic disease data bank.","volume":"50","author":"F Wolfe","year":"2011","journal-title":"Rheumatology (Oxford)."},{"issue":"3","key":"pone.0289760.ref061","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1136\/ard.60.3.199","article-title":"The national database of the German Collaborative Arthritis Centres: I. Structure, aims, and patients","volume":"60","author":"A Zink","year":"2001","journal-title":"Annals of the Rheumatic Diseases"},{"issue":"5 Suppl 85","key":"pone.0289760.ref062","first-page":"S-135","article-title":"The METEOR initiative: the way forward for optimal, worldwide data integration to improve care for RA patients","volume":"32","author":"R van den Berg","year":"2014","journal-title":"Clin Exp Rheumatol"},{"issue":"8","key":"pone.0289760.ref063","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1093\/rheumatology\/kes019","article-title":"Long-term outcome of patients with JIA treated with etanercept, results of the biologic register JuMBO.","volume":"51","author":"K Minden","year":"2012","journal-title":"Rheumatology (Oxford)."},{"issue":"4","key":"pone.0289760.ref064","doi-asserted-by":"crossref","first-page":"283","DOI":"10.3109\/s10165-007-0587-6","article-title":"Improvement of disease activity of rheumatoid arthritis patients from 2000 to 2006 in a large observational cohort study IORRA in Japan.","volume":"17","author":"H Yamanaka","year":"2007","journal-title":"Modern Rheumatology"},{"issue":"3","key":"pone.0289760.ref065","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.genhosppsych.2013.12.004","article-title":"Embedding integrated mental health assessment and management in general hospital settings: feasibility, acceptability and the prevalence of common mental disorder.","volume":"36","author":"L Rayner","year":"2014","journal-title":"General hospital psychiatry."},{"issue":"1","key":"pone.0289760.ref066","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1186\/s12891-016-1083-y","article-title":"Usefulness of the SF-36 Health Survey in screening for depressive and anxiety disorders in rheumatoid arthritis.","volume":"17","author":"F Matcham","year":"2016","journal-title":"BMC Musculoskeletal Disorders."},{"issue":"1","key":"pone.0289760.ref067","doi-asserted-by":"crossref","first-page":"e000074","DOI":"10.1136\/rmdopen-2015-000074","article-title":"The majority of newly diagnosed patients with juvenile idiopathic arthritis reach an inactive disease state within the first year of specialised care: data from a German inception cohort.","volume":"1","author":"C Sengler","year":"2015","journal-title":"RMD Open"},{"issue":"8","key":"pone.0289760.ref068","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1002\/acr.21680","article-title":"Early rheumatoid arthritis in Latin America: low socioeconomic status related to high disease activity at baseline.","volume":"64","author":"L Massardo","year":"2012","journal-title":"Arthritis care & research."},{"issue":"3","key":"pone.0289760.ref069","doi-asserted-by":"crossref","first-page":"155","DOI":"10.4081\/reumatismo.2011.155","article-title":"GISEA: an Italian biological agents registry in rheumatology.","volume":"63","author":"G Lapadula","year":"2011","journal-title":"Reumatismo"},{"issue":"1","key":"pone.0289760.ref070","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1093\/rheumatology\/keq318","article-title":"An evaluation of the strengths and weaknesses of a register of newly diagnosed rheumatoid arthritis, 1986\u20132010.","volume":"50","author":"A Young","year":"2011","journal-title":"Rheumatology (Oxford)."},{"issue":"9","key":"pone.0289760.ref071","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1093\/rheumatology\/kes078","article-title":"The prevalence of clinical remission in RA patients treated with anti-TNF: results from the Dutch Rheumatoid Arthritis Monitoring (DREAM) registry.","volume":"51","author":"YM de Punder","year":"2012","journal-title":"Rheumatology (Oxford)."},{"key":"pone.0289760.ref072","doi-asserted-by":"crossref","first-page":"737","DOI":"10.2147\/CLEP.S99490","article-title":"The Danish nationwide clinical register for patients with rheumatoid arthritis: DANBIO.","volume":"8","author":"EH Ibfelt","year":"2016","journal-title":"Clin Epidemiol"},{"issue":"5 Suppl 101","key":"pone.0289760.ref073","first-page":"S96","article-title":"The Corrona US registry of rheumatic and autoimmune diseases","volume":"34","author":"JM Kremer","year":"2016","journal-title":"Clin Exp Rheumatol"},{"issue":"5","key":"pone.0289760.ref074","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1093\/rheumatology\/39.5.542","article-title":"Clinical quality management in rheumatoid arthritis: putting theory into practice.","volume":"39","author":"E Uitz","year":"2000","journal-title":"Rheumatology"},{"issue":"5 Suppl 85","key":"pone.0289760.ref075","first-page":"S-147","article-title":"The Swedish Rheumatology Quality Register: optimisation of rheumatic disease assessments using register-enriched data","volume":"32","author":"JK Eriksson","year":"2014","journal-title":"Clin Exp Rheumatol"},{"issue":"6","key":"pone.0289760.ref076","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1136\/ard.2005.045872","article-title":"Swedish registers to examine drug safety and clinical issues in RA","volume":"65","author":"J Askling","year":"2006","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"pone.0289760.ref077","doi-asserted-by":"crossref","first-page":"82","DOI":"10.5152\/eurjrheum.2022.21060","article-title":"A real-life analysis of patients with rheumatologic diseases on biological treatments: Data from TURKBIO Registry.","volume":"9","author":"F \u00d6nen","year":"2022","journal-title":"Eur J Rheumatol"},{"issue":"1","key":"pone.0289760.ref078","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1093\/rheumatology\/keq220","article-title":"General characteristics of an early arthritis cohort in Argentina.","volume":"50","author":"J Marcos","year":"2010","journal-title":"Rheumatology"},{"issue":"11","key":"pone.0289760.ref079","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.3899\/jrheum.120029","article-title":"The Canadian Early Arthritis Cohort (CATCH): Patients with New-onset Synovitis Meeting the 2010 ACR\/EULAR Classification Criteria But Not the 1987 ACR Classification Criteria Present with Less Severe Disease Activity.","volume":"39","author":"VP Bykerk","year":"2012","journal-title":"The Journal of Rheumatology"},{"issue":"1","key":"pone.0289760.ref080","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s12969-017-0160-6","article-title":"The new Childhood Arthritis and Rheumatology Research Alliance (CARRA) registry: design, rationale, and characteristics of patients enrolled in the first 12 months.","volume":"15","author":"T Beukelman","year":"2017","journal-title":"Pediatric Rheumatology."},{"issue":"7","key":"pone.0289760.ref081","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1093\/rheumatology\/ken085","article-title":"Association between duration of symptoms and severity of disease at first presentation to paediatric rheumatology: results from the Childhood Arthritis Prospective Study.","volume":"47","author":"N Adib","year":"2008","journal-title":"Rheumatology"},{"issue":"Suppl2","key":"pone.0289760.ref082","first-page":"171","article-title":"Do depressive symptoms at disease onset associate with future disease activity for adolescent patients with JIA? Results from the Childhood Arthritis Prospective Study (CAPS).","volume":"75","author":"L Hanns","year":"2016","journal-title":"Annals of Rheumatic Disease."},{"issue":"12","key":"pone.0289760.ref083","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1136\/annrheumdis-2012-202031","article-title":"Validity of a three-variable Juvenile Arthritis Disease Activity Score in children with new-onset juvenile idiopathic arthritis","volume":"72","author":"F McErlane","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"pone.0289760.ref084","author":"K. Hyrich","year":"2018","journal-title":"STUDY PROTOCOL British Society for Rheumatology Biologics Register for Rheumatoid Arthritis (BSRBR-RA) v2.0_05122018"},{"issue":"1","key":"pone.0289760.ref085","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1093\/rheumatology\/keq263","article-title":"Using genetic and clinical data to understand response to disease-modifying anti-rheumatic drug therapy: data from the Brigham and Women\u2019s Hospital Rheumatoid Arthritis Sequential Study.","volume":"50","author":"CK Iannaccone","year":"2010","journal-title":"Rheumatology"},{"issue":"8","key":"pone.0289760.ref086","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1002\/acr.22290","article-title":"Effectiveness and Safety of Infliximab in Rheumatoid Arthritis: Analysis From a Canadian Multicenter Prospective Observational Registry.","volume":"66","author":"C Thorne","year":"2014","journal-title":"Arthritis Care & Research."},{"issue":"10","key":"pone.0289760.ref087","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1007\/s10067-015-3066-z","article-title":"Retention of the second-line biologic disease-modifying antirheumatic drugs in patients with rheumatoid arthritis failing one tumor necrosis factor alpha inhibitor: data from the BioRx.si registry.","volume":"34","author":"Z Rotar","year":"2015","journal-title":"Clin Rheumatol."},{"issue":"1","key":"pone.0289760.ref088","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1186\/s12891-016-1270-x","article-title":"Erratum to: Validity of data collected in BIOREG, the Austrian register for biological treatment in rheumatology: current practice of bDMARD therapy in rheumatoid arthritis in Austria.","volume":"17","author":"B Rintelen","year":"2016","journal-title":"BMC Musculoskelet Disord"},{"issue":"1","key":"pone.0289760.ref089","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1093\/rheumatology\/keq232","article-title":"Associations of disease activity and treatments with mortality in men with rheumatoid arthritis: results from the VARA registry.","volume":"50","author":"TR Mikuls","year":"2010","journal-title":"Rheumatology"},{"issue":"9","key":"pone.0289760.ref090","doi-asserted-by":"crossref","first-page":"2725","DOI":"10.1007\/s00296-011-2037-1","article-title":"An association study of disease activity score components and patient satisfaction with overall health for early RA patients on non-biologic DMARD therapy.","volume":"32","author":"SA Kovalchik","year":"2012","journal-title":"Rheumatol Int"},{"issue":"5","key":"pone.0289760.ref091","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1136\/annrheumdis-2011-201060","article-title":"Effectiveness and safety of a second and third biological agent after failing etanercept in juvenile idiopathic arthritis: results from the Dutch National ABC Register","volume":"72","author":"MH Otten","year":"2013","journal-title":"Annals of the Rheumatic Diseases"},{"issue":"6","key":"pone.0289760.ref092","doi-asserted-by":"crossref","first-page":"760","DOI":"10.3899\/jrheum.170778","article-title":"Patient-reported Outcomes, Resource Use, and Social Participation of Patients with Rheumatoid Arthritis Treated with Biologics in Alberta: Experience of Indigenous and Non-indigenous Patients","volume":"45","author":"C Barnabe","year":"2018","journal-title":"The Journal of Rheumatology"},{"issue":"1","key":"pone.0289760.ref093","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1471-2474-15-14","article-title":"Real-world effectiveness of abatacept for rheumatoid arthritis treatment in European and Canadian populations: a 6-month interim analysis of the 2-year, observational, prospective ACTION study.","volume":"15","author":"HG N\u00fc\u00dflein","year":"2014","journal-title":"BMC Musculoskeletal Disorders."},{"issue":"10","key":"pone.0289760.ref094","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1007\/s10067-013-2303-6","article-title":"Abatacept and its use in the treatment of rheumatoid arthritis (RA) in the Czech Republic\u2014data from the ATTRA registry.","volume":"32","author":"P Hor\u00e1k","year":"2013","journal-title":"Clinical Rheumatology."},{"issue":"4","key":"pone.0289760.ref095","doi-asserted-by":"crossref","first-page":"e2","DOI":"10.1016\/j.semarthrit.2010.10.001","article-title":"The Australian Rheumatology Association Database (ARAD).","volume":"40","author":"MP Williams","year":"2011","journal-title":"Seminars in Arthritis and Rheumatism"},{"issue":"5","key":"pone.0289760.ref096","first-page":"1174","article-title":"Arthritis, Rheumatism and Aging Medical Information System Post-Marketing Surveillance Program.","volume":"28","author":"G Singh","year":"2001","journal-title":"The Journal of Rheumatology"},{"key":"pone.0289760.ref097","doi-asserted-by":"crossref","first-page":"1273.3","DOI":"10.1136\/annrheumdis-2015-eular.5309","article-title":"AB1115 The Characteristics of Therapy of Patients with Rheumatoid Arthritis in the Russian Federation According to the Russian Register","volume":"74","author":"D Karateev","year":"2015","journal-title":"Annals of the Rheumatic Diseases"},{"key":"pone.0289760.ref098","doi-asserted-by":"crossref","first-page":"207","DOI":"10.2147\/OARRR.S218448","article-title":"A Swedish register-based, long-term inception cohort study of patients with rheumatoid arthritis\u2014results of clinical relevance.","volume":"11","author":"I Hafstr\u00f6m","year":"2019","journal-title":"Open Access Rheumatol"},{"issue":"9","key":"pone.0289760.ref099","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1093\/rheumatology\/kev429","article-title":"Factors associated with choice of biologic among children with Juvenile Idiopathic Arthritis: results from two UK paediatric biologic registers.","volume":"55","author":"L Kearsley-Fleet","year":"2016","journal-title":"Rheumatology"},{"key":"pone.0289760.ref100","author":"K. Hyrich","year":"2022","journal-title":"CURRENT DOCUMENT LIST\u2013Biologics for Children with Rheumatic Diseases (BCRD)"},{"issue":"4","key":"pone.0289760.ref101","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1136\/ard.2007.087593","article-title":"Safety and efficacy of combination of etanercept and methotrexate compared to treatment with etanercept only in patients with juvenile idiopathic arthritis (JIA): preliminary data from the German JIA Registry.","volume":"68","author":"G Horneff","year":"2009","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"pone.0289760.ref102","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1002\/acr.22112","article-title":"Improvement in health-related quality of life for children with juvenile idiopathic arthritis after start of treatment with etanercept.","volume":"66","author":"J Klotsche","year":"2014","journal-title":"Arthritis Care Res (Hoboken)."},{"issue":"4","key":"pone.0289760.ref103","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.reumae.2017.08.005","article-title":"Objectives and methodology of BIOBADASER phase III.","volume":"15","author":"C Sanchez-Piedra","year":"2019","journal-title":"Reumatolog\u00eda Cl\u00ednica (English Edition)."},{"issue":"9","key":"pone.0289760.ref104","doi-asserted-by":"crossref","first-page":"e0163087","DOI":"10.1371\/journal.pone.0163087","article-title":"Exploring the Inflammatory Metabolomic Profile to Predict Response to TNF-\u03b1 Inhibitors in Rheumatoid Arthritis.","volume":"11","author":"BVJ Cuppen","year":"2016","journal-title":"PLOS ONE."},{"issue":"3","key":"pone.0289760.ref105","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1002\/hec.4730020305","article-title":"The rand 36-item health survey 1.0","volume":"2","author":"RD Hays","year":"1993","journal-title":"Health Economics"},{"issue":"2","key":"pone.0289760.ref106","doi-asserted-by":"crossref","first-page":"e002346","DOI":"10.1136\/rmdopen-2022-002346","article-title":"Meaning of patient global assessment when joint counts are low in rheumatoid arthritis.","volume":"8","author":"DT Felson","year":"2022","journal-title":"RMD Open."},{"issue":"4","key":"pone.0289760.ref107","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1080\/10245330701340734","article-title":"ESR or CRP? A comparison of their clinical utility","volume":"12","author":"A Osei-Bimpong","year":"2007","journal-title":"Hematology"},{"issue":"3","key":"pone.0289760.ref108","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1136\/ard.2011.149765","article-title":"American College of Rheumatology\/European League against Rheumatism provisional definition of remission in rheumatoid arthritis for clinical trials","volume":"70","author":"DT Felson","year":"2011","journal-title":"Ann Rheum Dis"},{"issue":"11","key":"pone.0289760.ref109","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1136\/ard.49.11.916","article-title":"Judging disease activity in clinical practice in rheumatoid arthritis: first step in the development of a disease activity score","volume":"49","author":"DM van der Heijde","year":"1990","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"pone.0289760.ref110","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1093\/rheumatology\/keg072","article-title":"A simplified disease activity index for rheumatoid arthritis for use in clinical practice.","volume":"42","author":"JS Smolen","year":"2003","journal-title":"Rheumatology (Oxford)."},{"issue":"6","key":"pone.0289760.ref111","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1136\/ard.2010.142901","article-title":"Finalisation and validation of the rheumatoid arthritis impact of disease score, a patient-derived composite measure of impact of rheumatoid arthritis: a EULAR initiative","volume":"70","author":"L Gossec","year":"2011","journal-title":"Annals of the Rheumatic Diseases"},{"issue":"7","key":"pone.0289760.ref112","first-page":"1138","article-title":"A reevaluation of the symptom of morning stiffness","volume":"20","author":"JM Hazes","year":"1993","journal-title":"J Rheumatol"},{"issue":"12","key":"pone.0289760.ref113","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1016\/j.pain.2014.09.014","article-title":"Cut-off points for mild, moderate, and severe pain on the visual analogue scale for pain in patients with chronic musculoskeletal pain","volume":"155","author":"AM Boonstra","year":"2014","journal-title":"Pain"},{"issue":"11","key":"pone.0289760.ref114","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1002\/acr.20282","article-title":"Measuring fatigue in rheumatoid arthritis: A cross-sectional study to evaluate the Bristol Rheumatoid Arthritis Fatigue Multi-Dimensional questionnaire, visual analog scales, and numerical rating scales.","volume":"62","author":"J Nicklin","year":"2010","journal-title":"Arthritis Care & Research."},{"issue":"7","key":"pone.0289760.ref115","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1093\/rheumatology\/kel021","article-title":"Fatigue in rheumatoid arthritis reflects pain, not disease activity.","volume":"45","author":"LC Pollard","year":"2006","journal-title":"Rheumatology (Oxford)."},{"issue":"5 Suppl 39","key":"pone.0289760.ref116","first-page":"S14","article-title":"The Health Assessment Questionnaire (HAQ).","volume":"23","author":"B Bruce","year":"2005","journal-title":"Clin Exp Rheumatol"},{"issue":"5","key":"pone.0289760.ref117","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1192\/bjp.180.5.461","article-title":"The Work and Social Adjustment Scale: a simple measure of impairment in functioning","volume":"180","author":"JC Mundt","year":"2002","journal-title":"The British Journal of Psychiatry"},{"issue":"51","key":"pone.0289760.ref118","first-page":"1","article-title":"Development of the Rheumatoid Arthritis Distress Scale (RADS)\u2013A New Tool to Identify Disease-Specific Distress in Patients with Rheumatoid Arthritis.","volume":"5","author":"L Silke","year":"2021"},{"issue":"2","key":"pone.0289760.ref119","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.semarthrit.2019.02.004","article-title":"Risk profiling for a refractory course of rheumatoid arthritis","volume":"49","author":"M Becede","year":"2019","journal-title":"Semin Arthritis Rheum"},{"key":"pone.0289760.ref120","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/s41584-020-00541-7","article-title":"Persistent inflammatory and non-inflammatory mechanisms in refractory rheumatoid arthritis","volume":"17","author":"MH Buch","year":"2021","journal-title":"Nature Reviews Rheumatology"},{"issue":"9","key":"pone.0289760.ref121","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1007\/s40265-020-01309-9","article-title":"Understanding Refractory Rheumatoid Arthritis: Implications for a Therapeutic Approach.","volume":"80","author":"AR Melville","year":"2020","journal-title":"Drugs"},{"issue":"n\/a","key":"pone.0289760.ref122","article-title":"Outcomes Reported in Prospective Long-Term Observational Studies and Registries of Patients with Rheumatoid Arthritis Worldwide: An OMERACT Systematic Review.","volume":"n\/a","author":"MA Lopez-Olivo","year":"2020","journal-title":"Arthritis Care & Research."},{"issue":"5","key":"pone.0289760.ref123","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1136\/annrheumdis-2015-208274","article-title":"Measurements, composite scores and the art of \u2018cutting-off\u2019.","volume":"75","author":"PM Machado","year":"2016","journal-title":"Annals of the Rheumatic Diseases"},{"issue":"1","key":"pone.0289760.ref124","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1186\/s13075-021-02560-5","article-title":"Identification and prediction of difficult-to-treat rheumatoid arthritis patients in structured and unstructured routine care data: results from a hackathon.","volume":"23","author":"MA Messelink","year":"2021","journal-title":"Arthritis Research & Therapy."},{"issue":"8","key":"pone.0289760.ref125","doi-asserted-by":"crossref","first-page":"3778","DOI":"10.1093\/rheumatology\/keaa860","article-title":"Difficult-to-treat rheumatoid arthritis: contributing factors and burden of disease.","volume":"60","author":"NMT Roodenrijs","year":"2020","journal-title":"Rheumatology"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0289760","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,18]],"date-time":"2023-12-18T15:06:29Z","timestamp":1702911989000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0289760"}},"subtitle":[],"editor":[{"given":"Ryu","family":"Watanabe","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2023,8,9]]},"references-count":125,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2023,8,9]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0289760","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2022.09.15.22279984","asserted-by":"object"}]},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,9]]}}}